IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for IRADIMED CORPORATION stock has a target of 72, which predicts a -27.86% decrease from the current stock price of 99.81.

Price Target: $72 (-27.86%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$72	$72	$72	$72
Change	-27.86%	-27.86%	-27.86%	-27.86%

* Price targets were last updated on Feb 14, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for IRADIMED CORPORATION is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Wittes Roth MKM	Roth MKM	Strong Buy Reiterates $60 → $72	Strong Buy	Reiterates	$60 → $72	-27.86%	Feb 14, 2025
Jason Wittes Roth MKM	Roth MKM	Strong Buy Maintains $65 → $60	Strong Buy	Maintains	$65 → $60	-39.89%	Aug 2, 2024
Jason Wittes Roth MKM	Roth MKM	Strong Buy Initiates $65	Strong Buy	Initiates	$65	-34.88%	Apr 22, 2024
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $32 → $36	Strong Buy	Maintains	$32 → $36	-63.93%	Aug 2, 2021
Chris Lewis Roth Capital	Roth Capital	Strong Buy Initiates $16	Strong Buy	Initiates	$16	-83.97%	Oct 31, 2017

More Analyst Ratings

Financial Forecast

Revenue This Year

92.91M

Increased by 10.85%

from 83.81M

Revenue Next Year

96.37M

Increased by 3.72%

from 92.91M

EPS This Year

2.16

Increased by 23.57%

from 1.75

EPS Next Year

2.15

Decreased by -0.47%

from 2.16

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	41.81M	53.30M	65.56M	73.24M	83.81M	92.91M	96.37M
Revenue Growth	31.84%	27.48%	23.00%	11.71%	14.43%	10.85%	3.72%
EPS	0.74	1.02	1.35	1.50	1.75	2.16	2.15
EPS Growth	572.73%	37.84%	32.35%	11.11%	16.67%	23.57%	-0.47%
Forward PE	-	-	-	-	-	46.16	46.38
No. Analysts	-	-	-	-	-	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	95.8M	99.2M
Avg	92.9M	96.4M
Low	89.2M	92.6M

Revenue Growth

Revenue Growth	2026	2027
High	14.3%	6.8%
Avg	10.9%	3.7%
Low	6.4%	-0.3%

EPS Forecast

EPS	2026	2027
High	2.23	2.22
Avg	2.16	2.15
Low	2.08	2.07

EPS Growth

EPS Growth	2026	2027
High	27.2%	2.5%
Avg	23.6%	-0.5%
Low	18.7%	-4.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.